Blackstone to sell Japan supplement maker Alinamin to MBK for $2.2bn – Nikkei Asia
TOKYO — Asian investment fund MBK Partners will buy Japan’s Alinamin Pharmaceutical, a maker of supplements and nonprescription drugs, …Read More
The Heartbeat of World events
TOKYO — Asian investment fund MBK Partners will buy Japan’s Alinamin Pharmaceutical, a maker of supplements and nonprescription drugs, …Read More